| Label | Id | |
|---|---|---|
| Biomedical Research Integrated Domain Group Model, 1609D | CONC:SRC | |
| NCI2016_BRIDG_1609D | CONC:SRC | |
| LNC-FR-BE_258 | CONC:SRC | |
| LOINC, French, Belgium Edition, 258 | CONC:SRC | |
| NCI2016_CTEP-SDC_1609D | CONC:SRC | |
| Cancer Therapy Evaluation Program - Simple Disease Classification, 1609D | CONC:SRC | |
| LOINC, 258_2017_02_08 | CONC:SRC | |
| NCI2016_CTCAE_1609D | CONC:SRC | |
| Common Terminology Criteria for Adverse Events, 1609D | CONC:SRC | |
| Human Phenotype Ontology, 2016_09_03 | CONC:SRC | |
| HPO2016_09_03 | CONC:SRC | |
| Veterans Health Administration National Drug File, 2017_01_19 | CONC:SRC | |
| VANDF_2017_01_19 | CONC:SRC | |
| NDFRT_FMTSME_2017_03_06 | CONC:SRC | |
| National Drug File - FMTSME, 2017_03_06 | CONC:SRC |